Eisai, a research-based human health care company, has appointed Allen Waxman as general counsel and senior vice president, effective immediately.

In his new role, Waxman will lead the office of the general counsel, responsible for all Eisai's U.S. legal matters. He will also be a member of the executive committee.

Previously, Waxman served as partner and chair of the life sciences group at Kaye Scholer. Prior to that, he served as general counsel at Pfizer, where he lead the legal division and also served on the company's executive leadership team. He also served as a partner at law firm Williams & Connolly, where he tried civil and criminal cases, and served as national counsel in pharmaceutical litigation.